PROMUS PATHWAY utilizes molecular Real-time PCR technology coupled with customized proprietary panels of multiplexed microbes and antibiotic drug resistance targets which provides precise results enabling treatment within 24 hours.
High Resolution Melt (HRM) Capabilities • Mutation Detection • SNP genotyping • MicroRNA profiling
The Centers for Disease Control and Prevention estimate at least 2 million people each year are infected with antibiotic resistant bacteria across the U.S.
Using the PhenoPathway™ system with positive qPCR test results, Promus Diagnostics can substantially reduce the processing time by testing directly from positive urine samples, which enables clinicians to provide patients optimal therapy up to 40 hours faster than conventional methods.
Decreases time to effective therapy • Optimize therapy specific to patient • Improve patient outcomes • Decrease Antimicrobial Resistance • Lowers cost of treatment • Meaningful antibiotic stewardship